title: Protective effects of a free radical scavenger, MCI-186, on high-glucose-induced dysfunction of human dermal microvascular endothelial cells.
abstract: Functional damage to microvascular endothelial cells by hyperglycemia is thought to be one of the critical risk factors in the impaired wound healing seen with diabetes mellitus. It is also thought that free radical stress plays a significant role in this endothelial cell dysfunction. In the present study, the effect of a free radical scavenger, MCI 186, on the endothelial cell dysfunction of cultured cells induced by high-glucose conditions was studied. Human dermal microvascular endothelial cells were cultured with high-glucose medium (50 mM) with or without MCI-186 (10 microM) for 7 days. Fifty mM mannitol was used as an osmotic control in this study. After this treatment, cell proliferation, activation of mitogen-activated protein kinase (MAPK), the level of apoptosis, and caspase-3 activation induced by removal of growth factors or tumor necrosis factor-alpha treatment were studied. High-glucose conditions significantly decreased cell proliferation and increased apoptosis levels with the activation of caspase-3 induced by growth factor removal. The high-glucose condition significantly activated MAPK. MCI-186 treatment improved cellular proliferation and reduced apoptosis and caspase-3 activation induced by high-glucose conditions. MCI-186 also inhibited the activation of MAPK. On the other hand, MCI-186 did not alter the level of apoptosis and caspase-3 activation induced by TNF-alpha treatment. In conclusion, we suggest that MCI-186 may be beneficial for improving the endothelial cell dysfunction induced by hyperglycemia.
authors.affiliation: Department of Plastic Surgery, Kyorin University School of Medicine, Tokyo 181-8611, Japan.
authors.forename: Jiaoyun
authors.initials: J
authors.lastname: Dong
authors.forename: Dong
authors.initials: D
authors.lastname: Jiaojun
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Takami
authors.forename: Hideharu
authors.initials: H
authors.lastname: Tanaka
authors.forename: Ryo
authors.initials: R
authors.lastname: Yamaguchi
authors.forename: Guo
authors.initials: G
authors.lastname: Jingping
authors.forename: Qing
authors.initials: Q
authors.lastname: Chun
authors.forename: Lu
authors.initials: L
authors.lastname: Shuliang
authors.forename: Shuji
authors.initials: S
authors.lastname: Shimazaki
authors.forename: Ken
authors.initials: K
authors.lastname: Ogo
mesh_terms: D000983:Antipyrine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D017209:Apoptosis; D015153:Blotting, Western; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism; D049109:Cell Proliferation; D002478:Cells, Cultured; D000077553:Edaravone; D042783:Endothelial Cells / Q000187:drug effects*; D016166:Free Radical Scavengers / Q000494:pharmacology*; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology*; D008833:Microcirculation; D048052:Mitogen-Activated Protein Kinase 3 / Q000378:metabolism; D012867:Skin / Q000098:blood supply*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D016166:Free Radical Scavengers; D014409:Tumor Necrosis Factor-alpha; D048052:Mitogen-Activated Protein Kinase 3; C505407:CASP3 protein, human; D053148:Caspase 3; D020169:Caspases; D000077553:Edaravone; D000983:Antipyrine